jmt101
Showing 1 - 5 of 5
Metastatic Colorectal Cancer (mCRC) Trial (JMT101, SG001, Irinotecan)
Not yet recruiting
- Metastatic Colorectal Cancer (mCRC)
- JMT101
- +3 more
- (no location specified)
Oct 13, 2023
Esophageal Squamous Carcinoma Trial in China (JMT101, Afatinib)
Recruiting
- Esophageal Squamous Carcinoma
- JMT101
- Afatinib
-
Beijing, Beijing, China
- +4 more
Dec 18, 2021
Locally Advanced or Metastatic NSCLC, EGFR Exon20 Insertion Mutations Trial (JMT101, Osimertinib Mesylate Tablets)
Not yet recruiting
- Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- EGFR Exon20 Insertion Mutations
- JMT101
- Osimertinib Mesylate Tablets
- (no location specified)
Nov 12, 2021
Advanced Solid Tumor Trial in China (JMT101)
Recruiting
- Advanced Solid Tumor
- JMT101
-
Beijing, China
- +8 more
Dec 25, 2020
Locally Advanced or Metastatic NSCLC Trial in China (JMT101)
Unknown status
- Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- JMT101
-
Guangzhou, Guangdong, China
- +12 more
Dec 23, 2020